Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

DOI: 10.1634/theoncologist.2015-0381

Keywords: Neuroendocrine tumors, Malignant carcinoid syndrome, Somatostatin analogue, SEER-Medicare

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text